Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

755 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial-rationale and design.
Verghese D, Hamal S, Ghanem A, Kinninger A, Javier D, Ichikawa K, Benzing T, Krishnan S, Kianoush S, Hamidi H, Bagheri M, Abraham D, Deljavanghodrati M, Ghoto A, Aldana-Bitar J, Budoff M. Verghese D, et al. Among authors: ghanem a. Am Heart J. 2024 Nov;277:20-26. doi: 10.1016/j.ahj.2024.07.005. Epub 2024 Jul 17. Am Heart J. 2024. PMID: 39029568
COVID-19 IgG/IgM antibody testing in Los Angeles County, California.
Ahmad K, Rezvanizadeh V, Dahal S, Kinninger A, Ghanem AK, Lakshmanan S, Hamal S, Flores F, Dailing C, Roy SK, Budoff MJ. Ahmad K, et al. Among authors: ghanem ak. Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):457-459. doi: 10.1007/s10096-020-04111-3. Epub 2020 Nov 25. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33241444 Free PMC article.
Prevalence of normal coronary arteries by coronary computed tomography angiography (CCTA) in patients with type 2 diabetes mellitus from Semaglutide Treatment on Coronary Plaque Progression (STOP) trial.
Birudaraju D, Cherukuri L, Kinninger A, Dahal S, Lakshmanan S, Rezvanizadeh V, Ghanem AK, Flores F, Hamal S, Pozon RG, Adudodla N, Tayek JA, Roy SK, Budoff MJ. Birudaraju D, et al. Among authors: ghanem ak. J Diabetes Complications. 2021 Mar;35(3):107840. doi: 10.1016/j.jdiacomp.2020.107840. Epub 2020 Dec 31. J Diabetes Complications. 2021. PMID: 33419635 Clinical Trial.
Coronary computed tomography angiography evaluation of plaque morphology and its relationship to HDL and total cholesterol to HDL ratio.
Manubolu VS, Verghese D, Lakshmanan S, Alalawi L, Kinninger A, Bitar JA, Calicchio F, Ahmad K, Ghanem A, Javier DA, Mangaoang C, Flores F, Dailing C, Roy SK, Budoff MJ. Manubolu VS, et al. Among authors: ghanem a. J Clin Lipidol. 2022 Sep-Oct;16(5):715-724. doi: 10.1016/j.jacl.2022.06.003. Epub 2022 Jun 19. J Clin Lipidol. 2022. PMID: 35778256
The impact of carbohydrate restriction-induced elevations in low-density lipoprotein cholesterol on progression of coronary atherosclerosis: the ketogenic diet trial study design.
Javier DAR, Manubolu VS, Norwitz NG, Kinninger A, Aldana-Bitar J, Ghanem A, Ahmad K, Vicuna WD, Hamidi H, Bagheri M, Elsayed T, Villanueva B, Ichikawa K, Flores F, Hamal S, Feldman D, Budoff MJ. Javier DAR, et al. Among authors: ghanem a. Coron Artery Dis. 2024 Nov 1;35(7):577-583. doi: 10.1097/MCA.0000000000001395. Epub 2024 Jun 13. Coron Artery Dis. 2024. PMID: 38861193 Free PMC article.
Exploring the relationship between epicardial fat and coronary plaque burden and characteristics: insights from cardiac ct imaging.
Manubolu VS, Lu JY, Montano B, Kininger A, Bainiwal J, Verghese D, Alalawi L, Bitar JA, Pourafkari L, Fazlalizadeh H, Ichikawa K, Khadije A, Denise J, Ghanem A, Hamal S, Mao S, Budoff MJ, Roy SK. Manubolu VS, et al. Among authors: ghanem a. Int J Cardiovasc Imaging. 2024 Sep;40(9):1951-1959. doi: 10.1007/s10554-024-03186-9. Epub 2024 Jul 15. Int J Cardiovasc Imaging. 2024. PMID: 39008195
Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the tirzepatide treatment on coronary atherosclerosis progression: The (T-Plaque) randomized-controlled trial design.
Hamidi H, Bagheri M, Benzing T, Krishnan S, Kianoush S, Ichikawa K, Ghanem AK, Javier D, Iskander B, Aldana-Bitar J, Budoff MJ. Hamidi H, et al. Am Heart J. 2024 Dec;278:24-32. doi: 10.1016/j.ahj.2024.08.015. Epub 2024 Aug 24. Am Heart J. 2024. PMID: 39187147
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
755 results